FENNEC PHARMACEUTICALS INC. Quarterly Current Ratio in % from Q2 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Fennec Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q2 2019 to Q3 2024.
  • Fennec Pharmaceuticals Inc. Current Ratio for the quarter ending September 30, 2024 was 661 %, a 23% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 661 +124 +23% Sep 30, 2024
Q2 2024 610 -28.7 -4.49% Jun 30, 2024
Q1 2024 535 -110 -17% Mar 31, 2024
Q4 2023 456 -265 -36.8% Dec 31, 2023
Q3 2023 537 -357 -40% Sep 30, 2023
Q2 2023 638 Jun 30, 2023
Q1 2023 645 Mar 31, 2023
Q4 2022 720 Dec 31, 2022
Q3 2022 894 Sep 30, 2022
Q2 2021 1.35K +404 +42.5% Jun 30, 2021
Q1 2021 1.17K +280 +31.6% Mar 31, 2021
Q4 2020 1.11K -18.2 -1.62% Dec 31, 2020
Q3 2020 946 -484 -33.9% Sep 30, 2020
Q2 2020 949 -367 -27.9% Jun 30, 2020
Q1 2020 888 Mar 31, 2020
Q4 2019 1.13K Dec 31, 2019
Q3 2019 1.43K Sep 30, 2019
Q2 2019 1.32K Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.